Abbott SARS-Cov-2 Antibody Test Had 100% Sensitivity in Study

May 8, 2020, 1:06 PM

Abbott said that new research, published in the Journal of Clinical Microbiology found that its SARS-CoV-2 IgG lab-based serology blood test had 99.9% specificity and 100% sensitivity for detecting the IgG antibody in patients 17 days or more after symptoms began

  • Independent research was conducted by University of Washington School of Medicine in Seattle

To view the source of this information click here

To contact the reporter on this story:
Sonali Pathirana in New York at spathirana@bloomberg.net

To contact the editor responsible for this story:
Stephen Foxwell at sfoxwell@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

To read the full article log in.

Learn more about a Bloomberg Law subscription.